Medical Science Liaison – Rett Syndrome, Germany
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
Acadia Pharmaceuticals seeks an experienced Medical Science Liaison (MSL) to advance Rett syndrome and related rare pediatric diseases in Germany.
Qualifiche, competenze e l'esperienza necessaria per questo ruolo sono disponibili nella descrizione completa riportata di seguito.
You will build relationships with thought leaders, support clinical research, and collaborate with cross-functional teams while maintaining medical governance.
The ideal candidate holds an advanced scientific or medical degree (MD/PhD preferred), xlwpduy with 6–8 years in the industry including 3–5 years as an MSL in CNS/rare disease, and is fluent in German
-
Turin, Piedmont, Italia Acadia Job Listings Tempo pienoAbout Acadia PharmaceuticalsAcadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the...
-
Medical Science Liaison – Rett Syndrome, Germany
2 giorni fa
Turin, Piedmont, Italia Acadia Job Listings Tempo pienoAcadia Pharmaceuticals seeks an experienced Medical Science Liaison (MSL) to advance Rett syndrome and related rare pediatric diseases in Germany.Qualifiche, competenze e l'esperienza necessaria per questo ruolo sono disponibili nella descrizione completa riportata di seguito.You will build relationships with thought leaders, support clinical research, and...
-
(Sr.) Medical Scientific Liaison Germany
2 giorni fa
Turin, Piedmont, Italia Acadia Job Listings Tempo pienoAbout Acadia PharmaceuticalsAcadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the...